Related Experiment Video

Updated: May 30, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Epidemiology and costs of hypertension-related disorders

Aldo Leone1, Linda Landini, Aurelio Leone

  • 1Cometa Consortium, La Spezia, Italy.

Current Pharmaceutical Design
|August 25, 2011
PubMed

Insights

Hypertension significantly increases cardiovascular risks, including heart attack and stroke. Current prevention strategies are costly and offer limited benefits, necessitating improved cost-benefit analyses for better public health outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Hypertension is a major risk factor for severe cardiovascular events such as myocardial infarction and stroke.
  • Existing prevention strategies for hypertension-related cardiovascular disorders incur substantial public health costs.
  • Current interventions show limited effectiveness, questioning their economic viability.

Purpose of the Study:

  • To evaluate the cost-effectiveness of current hypertension management strategies.
  • To identify the need for improved cost-benefit analyses in cardiovascular disease prevention.
  • To emphasize the importance of lowering blood pressure to reduce cardiovascular complications.

Main Methods:

  • Review of epidemiological data on cardiovascular disorders in hypertensive patients.
  • Analysis of large-scale trial data on the efficacy of current prevention methods.
  • Assessment of public health costs versus benefits of hypertension management.

Main Results:

  • Hypertensive patients exhibit a high incidence of cardiovascular events like ischemic heart disease and stroke.
  • Current non-pharmacological and pharmacological prevention methods are expensive and yield insufficient benefits.
  • The cost-benefit ratio of existing interventions requires significant improvement.

Conclusions:

  • Lowering blood pressure remains the primary goal for reducing cardiovascular complications in hypertension.
  • There is a critical need for enhanced quantitative measures to optimize public health spending on hypertension management.
  • Future strategies must better balance public health costs with achieved benefits for hypertensive patients.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...